A better understanding of the IL13/IL13Rα2 signaling pathway would facilitate the discovery of novel therapeutic candidates in those cancers characterized by high expression of IL13Rα2, such as colorectal, ovarian, or GBM. This evidence concerns the gene IL13 and cancer.